Evaluation of the prognostic significance of RACGAP1, Ki67, and TOP2A mRNA expression in high-risk early breast cancer.

被引：0
|
作者：
Pliarchopoulou, Kyriaki
Gogas, Helen
Papadimitriou, Christos A.
Wirtz, Ralph M.
Kouvalseas, George
Timotheadou, Eleni
Slavridi, Flora
Christodoulou, Christos
Koutras, Angelos
Pisanidis, Nikolaos
Pentheroudakis, George E.
Bafaloukos, Dimitris
Samantas, Epaminontas
Kalogeras, Konstantine T.
Dimopoulos, Meletios A.
Pectasides, Dimitrios G.
Fountzilas, George
机构：
[1] Hellen Cooperat Oncol Grp HeCOG, Athens, Greece
[2] STRATIFYER Mol Pathol GmbH, Cologne, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
582
引用
收藏
页数：1
相关论文
共 50 条
  • [41] TOP2A aberrations as predictive and prognostic marker in high-risk breast cancer patients.: A randomized DBCG trial (DBCG89D).
    Knoop, A.
    Knudsen, H.
    Balslev, E.
    Rasmussen, B. B.
    Overgaard, J.
    During, M.
    Nielsen, K. V.
    Jorgensen, J. T.
    Mouridsen, H.
    Ejlertsen, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 11S - 11S
  • [42] Prognostic value of VEGF-A mRNA expression in primary tumors of high-risk breast cancer patients
    Linardou, H.
    Fountzilas, G.
    Wirtz, R. M.
    Malamou-Mitsi, V.
    Stropp, U.
    Aravantinos, G.
    Pectasides, D.
    Gogas, H.
    Grimani, I.
    Koutras, A.
    Dafni, U.
    Hennig, G.
    Skarlos, D.
    Kalogeras, K. T.
    ANNALS OF ONCOLOGY, 2007, 18 : 47 - 47
  • [43] Significance of concurrent evaluation of HER2 gene amplification and p53 and Ki67 expression in gastric cancer tissues
    Wang, Su-nan
    Wang, Yang-kun
    Zhu, Chao-ya
    Jiang, Bo
    Ge, Dong-feng
    Li, Ying-ying
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2025, 27 (01): : 126 - 134
  • [44] Predictive and Prognostic Significance of mRNA Expression and DNA Copies Aberrations of ERCC1, RRM1, TOP1, TOP2A, TUBB3, TYMS, and GSTP1 Genes in Patients with Breast Cancer
    Tsyganov, Matvey M.
    Ibragimova, Marina K.
    Garbukov, Evgeniy Yu.
    Tsydenova, Irina A.
    Gaptulbarova, Kseniya A.
    Dolgasheva, Daria S.
    Zdereva, Ekaterina A.
    Frolova, Anastasia A.
    Slonimskaya, Elena M.
    Litviakov, Nikolai V.
    DIAGNOSTICS, 2022, 12 (02)
  • [45] TIMP-1 in combination with HER2 and TOP2A for prediction of benefit from adjuvant anthracyclines in high-risk breast cancer patients
    Pernille Braemer Hertel
    Dongsheng Tu
    Bent Ejlertsen
    Maj-Britt Jensen
    Eva Balslev
    Shan Jiang
    Frances P. O’Malley
    Kathleen I. Pritchard
    Lois E. Shepherd
    Annette Bartels
    Nils Brünner
    Torsten O. Nielsen
    Breast Cancer Research and Treatment, 2012, 132 : 225 - 234
  • [46] Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients
    Bertucci, F.
    Finetti, P.
    Roche, H.
    Le Doussal, J. M.
    Marisa, L.
    Martin, A. L.
    Lacroix-Triki, M.
    Blanc-Fournier, C.
    Jacquemier, J.
    Peyro-Saint-Paul, H.
    Viens, P.
    Sotiriou, C.
    Birnbaum, D.
    Penault-Llorca, F.
    ANNALS OF ONCOLOGY, 2013, 24 (03) : 625 - 632
  • [47] The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer
    Adamo, Barbara
    Rita Ricciardi, Giuseppina Rosaria
    Ieni, Antonio
    Franchina, Tindara
    Fazzari, Carmine
    Sano, Maria Vita
    Angelico, Giuseppe
    Michele, Caruso
    Tuccari, Giovanni
    Adamo, Vincenzo
    ONCOTARGET, 2017, 8 (44) : 76974 - 76986
  • [48] HER2, TOP2A, and TIMP-1 and Responsiveness to Adjuvant Anthracycline-Containing Chemotherapy in High-Risk Breast Cancer Patients
    Ejlertsen, Bent
    Jensen, Maj-Britt
    Nielsen, Kirsten V.
    Balslev, Eva
    Rasmussen, Birgitte B.
    Willemoe, Gro L.
    Hertel, Pernille B.
    Knoop, Ann S.
    Mouridsen, Henning T.
    Brunner, Nils
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (06) : 984 - 990
  • [49] Correlation of HER2/TOP2A Gene Aberrations with RASSF1A/APC Gene Methylation Status in High-Risk Breast Cancer
    Nursal, Ayse Feyda
    Cilingir, Oguz
    Eroglu, Onur
    Durak Aras, Beyhan
    Ciftci, Evrim
    Baydemir, Canan
    Artan, Sevilhan
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2020, 35 (01): : 8 - 14
  • [50] TIMP-1 in combination with HER2 and TOP2A for prediction of benefit from adjuvant anthracyclines in high-risk breast cancer patients
    Hertel, Pernille Braemer
    Tu, Dongsheng
    Ejlertsen, Bent
    Jensen, Maj-Britt
    Balslev, Eva
    Jiang, Shan
    O'Malley, Frances P.
    Pritchard, Kathleen I.
    Shepherd, Lois E.
    Bartels, Annette
    Brunner, Nils
    Nielsen, Torsten O.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (01) : 225 - 234
12345